Steven D. Pearson

491 total citations
28 papers, 250 citations indexed

About

Steven D. Pearson is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Steven D. Pearson has authored 28 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Economics and Econometrics and 6 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Steven D. Pearson's work include Intensive Care Unit Cognitive Disorders (6 papers), Respiratory Support and Mechanisms (5 papers) and Long-Term Effects of COVID-19 (5 papers). Steven D. Pearson is often cited by papers focused on Intensive Care Unit Cognitive Disorders (6 papers), Respiratory Support and Mechanisms (5 papers) and Long-Term Effects of COVID-19 (5 papers). Steven D. Pearson collaborates with scholars based in United States, Australia and India. Steven D. Pearson's co-authors include Bhakti K. Patel, David M. Rind, Susanne Salem‐Schatz, Melanie D. Whittington, Jonathan D. Campbell, Sean Tunis, Foluso Agboola, Francesca L. Beaudoin, Anne S. Pohlman and John P. Kress and has published in prestigious journals such as Annals of Internal Medicine, CHEST Journal and Critical Care Medicine.

In The Last Decade

Steven D. Pearson

27 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven D. Pearson United States 9 53 50 49 45 31 28 250
Dianne de Korte‐de Boer Netherlands 8 43 0.8× 11 0.2× 16 0.3× 17 0.4× 9 0.3× 23 262
George Tu United States 8 56 1.1× 51 1.0× 50 1.0× 51 1.1× 13 0.4× 8 341
Matthew Tews United States 13 55 1.0× 15 0.3× 9 0.2× 16 0.4× 21 0.7× 32 461
Sukdev Nayak India 8 52 1.0× 9 0.2× 33 0.7× 12 0.3× 7 0.2× 13 255
Namita Jayaprakash United States 9 36 0.7× 29 0.6× 60 1.2× 19 0.4× 12 0.4× 27 304
Wai-Cho Yu Hong Kong 6 68 1.3× 10 0.2× 34 0.7× 185 4.1× 13 0.4× 9 322
Jonathan Joseph United Kingdom 9 39 0.7× 13 0.3× 17 0.3× 35 0.8× 6 0.2× 16 249
Yoojin Lee United States 12 151 2.8× 5 0.1× 54 1.1× 15 0.3× 8 0.3× 29 355
Camila Souza Crovador Brazil 7 46 0.9× 33 0.7× 8 0.2× 40 0.9× 8 0.3× 11 343
Arpi Bekmezian United States 13 104 2.0× 13 0.3× 79 1.6× 64 1.4× 3 0.1× 27 444

Countries citing papers authored by Steven D. Pearson

Since Specialization
Citations

This map shows the geographic impact of Steven D. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven D. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven D. Pearson more than expected).

Fields of papers citing papers by Steven D. Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven D. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven D. Pearson. The network helps show where Steven D. Pearson may publish in the future.

Co-authorship network of co-authors of Steven D. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Steven D. Pearson. A scholar is included among the top collaborators of Steven D. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven D. Pearson. Steven D. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tice, Jeffrey A., Melanie D. Whittington, Abigail C. Wright, et al.. (2024). KarXT for schizophrenia–effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council. Journal of Managed Care & Specialty Pharmacy. 30(6). 624–628. 7 indexed citations
2.
3.
Trusheim, Mark, et al.. (2024). Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States. Journal of Comparative Effectiveness Research. 13(12). e240118–e240118. 9 indexed citations
4.
5.
Tice, Jeffrey A., et al.. (2023). The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum. Journal of Managed Care & Specialty Pharmacy. 29(5). 576–581. 6 indexed citations
6.
Atlas, Steven J., Kibum Kim, Daniel R. Touchette, et al.. (2023). Medications for obesity management: Effectiveness and value. Journal of Managed Care & Specialty Pharmacy. 29(5). 569–575. 21 indexed citations
7.
Pearson, Steven D., et al.. (2023). White bagging, brown bagging and site of service policies: best practices in addressing provider markup in the commercial insurance market. Journal of Comparative Effectiveness Research. 12(10). e230128–e230128. 2 indexed citations
8.
Beinfeld, Molly T., et al.. (2022). Oral treatments for outpatient COVID-19: Effectiveness and value. Journal of Managed Care & Specialty Pharmacy. 28(8). 903–909. 4 indexed citations
9.
Kogut, Stephen, et al.. (2022). The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics. Value in Health. 26(3). 378–383. 1 indexed citations
10.
Whittington, Melanie D., Steven D. Pearson, David M. Rind, & Jonathan D. Campbell. (2022). The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19. Value in Health. 25(5). 744–750. 20 indexed citations
11.
Rind, David M., et al.. (2022). The effectiveness and value of betibeglogene autotemcel for the management of transfusion-dependent beta-thalassemia. Journal of Managed Care & Specialty Pharmacy. 28(11). 1316–1320. 3 indexed citations
12.
13.
Pearson, Steven D., K.S. Wolfe, Anne S. Pohlman, et al.. (2021). Early Rehabilitation Feasibility in a COVID-19 ICU. CHEST Journal. 160(6). 2146–2148. 11 indexed citations
14.
Pearson, Steven D., Anne S. Pohlman, Julie Lin, et al.. (2021). Bedside estimates of dead space using end-tidal CO2 are independently associated with mortality in ARDS. Critical Care. 25(1). 333–333. 17 indexed citations
15.
Wolfe, K.S., Steven D. Pearson, Chris Ward, et al.. (2021). Functional and Quality of Life Outcomes of Critically Ill COVID-19 Survivors at Hospital Discharge and Six Months. A1212–A1212.
16.
17.
Pearson, Steven D. & Bhakti K. Patel. (2019). Evolving targets for sedation during mechanical ventilation. Current Opinion in Critical Care. 26(1). 47–52. 36 indexed citations
18.
Tunis, Sean & Steven D. Pearson. (2010). US moves to improve health decisions. BMJ. 341(aug23 1). c3615–c3615. 7 indexed citations
19.
Pearson, Steven D.. (1999). Principles of generalist-specialist relationships. Journal of General Internal Medicine. 14(S1). S13–S20. 31 indexed citations
20.
Salem‐Schatz, Susanne, et al.. (1994). The case for case-mix adjustment in practice profiling. When good apples look bad.. PubMed. 272(11). 871–4. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dianne de Korte‐de Boer Breakdown of academic impact, for papers by George Tu Breakdown of academic impact, for papers by Matthew Tews Breakdown of academic impact, for papers by Sukdev Nayak Breakdown of academic impact, for papers by Namita Jayaprakash Breakdown of academic impact, for papers by Wai-Cho Yu Breakdown of academic impact, for papers by Jonathan Joseph Breakdown of academic impact, for papers by Yoojin Lee Breakdown of academic impact, for papers by Camila Souza Crovador Breakdown of academic impact, for papers by Arpi Bekmezian
Rankless by CCL
2026